Shanghai Haohao Biotechnology

Shanghai Haohai Biological Technology is a leading Chinese biopharmaceutical company specializing in the development and manufacture of absorbable biomedical materials. The company's core business is organized into four key segments: ophthalmology, medical aesthetics, orthopedics, and wound care. Haohai is a dominant player in the Chinese market for intraocular lenses (IOLs), sodium hyaluronate injections for osteoarthritis, and ophthalmic viscosurgical devices (OVD). Additionally, the company has a significant presence in the medical aesthetics market with its range of hyaluronic acid dermal fillers and recombinant human epidermal growth factor products for wound healing. It is listed on both the Hong Kong Stock Exchange and the Shanghai Stock Exchange STAR Market.